BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31331930)

  • 21. ABO incompatibility and glucose-6-phosphate dehydrogenase deficiency presenting as Hydrops Foetalis.
    Suria AA; Nurasyikin Y; Adibah AG; Cheah FC; Leong CF
    Clin Ter; 2014; 165(3):151-4. PubMed ID: 24999569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune hydrops fetalis attributable to anti-HJK.
    Rouse D; Weiner C; Williamson R
    Obstet Gynecol; 1990 Nov; 76(5 Pt 2):988-90. PubMed ID: 2216274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythroblastosis and reticulocytosis in anemic fetuses.
    Nicolaides KH; Thilaganathan B; Rodeck CH; Mibashan RS
    Am J Obstet Gynecol; 1988 Nov; 159(5):1063-5. PubMed ID: 3189438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrops foetalis caused by anti-Mur in first pregnancy--a case report.
    Wu KH; Chang JG; Lin M; Shih MC; Lin H; Lee CC; Peng CT; Tsai CH
    Transfus Med; 2002 Oct; 12(5):325-7. PubMed ID: 12383339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemolytic disease and reticulocytopenia of the newborn attributable to maternal immunoglobulin G anti-M reacting optimally at cold temperatures.
    Andersen LH; Jacob EK; McThenia SS; Tauscher CD; Patterson ER; Oliveira JL; Rodriguez V
    Transfusion; 2021 Mar; 61(3):974-978. PubMed ID: 33444461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical study on 156 cases with hydrops fetalis].
    Lin SM; Wang CH; Zhu XY; Li SL; Lin SM; Fang Q
    Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):905-10. PubMed ID: 22333280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of extended c, E and K matching in females under 45 years of age on the incidence of transfusion-induced red blood cell alloimmunisation.
    Oud JA; Evers D; de Haas M; de Vooght KMK; van de Kerkhof D; Som N; Péquériaux NCV; Hudig F; Albersen A; van der Bom JG; Zwaginga JJ
    Br J Haematol; 2021 Nov; 195(4):604-611. PubMed ID: 34346067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Haemolytic disease of the newborn due to anti-Duffy (author's transl)].
    Schellong G; Möller B; Wagner H
    Dtsch Med Wochenschr; 1974 Dec; 99(51):2610-3. PubMed ID: 4434860
    [No Abstract]   [Full Text] [Related]  

  • 29. [Neonatal blood group incompatibility due to anti-M antibodies].
    Hoffmann JJ; Hutter AP; Loomans AA; Tielens AG
    Ned Tijdschr Geneeskd; 1991 May; 135(18):805-7. PubMed ID: 2052099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemolytic disease of the newborn due to maternal irregular antibodies in the Chinese population in Taiwan.
    Wu KH; Chu SL; Chang JG; Shih MC; Peng CT
    Transfus Med; 2003 Oct; 13(5):311-4. PubMed ID: 14617342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemolytic disease of the fetus and newborn.
    de Haas M; Thurik FF; Koelewijn JM; van der Schoot CE
    Vox Sang; 2015 Aug; 109(2):99-113. PubMed ID: 25899660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraperitoneal and intracardiac transfusion of recurrent fetal erythroblastosis due to anti-M alloimmunization with unfavorable outcome.
    Lin TH; Shih JC; Lin CH; Lin SY; Su YN; Lee CN
    Taiwan J Obstet Gynecol; 2012 Jun; 51(2):253-5. PubMed ID: 22795103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-C causing severe hemolytic disease of the fetus and newborn: a rare case report.
    Sahoo D; Anuragaa S; Abhishekh B
    Immunohematology; 2023 Apr; 39(1):11-14. PubMed ID: 37017597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anemic Disease of the Newborn With Little Increase in Hemolysis and Erythropoiesis Due to Maternal Anti-Jr
    Katsuragi S; Ohto H; Yoshida A; Otake A; Tsuneyama H; Ogasawara K; Isa K; Ikeda T
    Transfus Med Rev; 2019 Jul; 33(3):183-188. PubMed ID: 31227265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful perinatal management of hydrops fetalis due to hemolytic disease associated with D-- maternal phenotype.
    Aref K; Boctor FN; Pande S; Uehlinger J; Manning F; Eglowstein M; Mallozzi A; Bebbington M; Weinberg G; Rosen O; Raab C; Brion LP
    J Perinatol; 2002 Dec; 22(8):667-8. PubMed ID: 12478452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review.
    Blyth U; Larsson M; Baird A; Waring G; Athiraman N
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10220-10225. PubMed ID: 36121063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A descriptive single-centre experience of the management and outcome of maternal alloantibodies in pregnancy.
    Chatziantoniou V; Heeney N; Maggs T; Rozette C; Fountain C; Watts T; Harrison C; Pasupathy D; Sankaran S; Kyle P; Robinson S
    Transfus Med; 2017 Aug; 27(4):275-285. PubMed ID: 28608631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemolytic disease of the fetus and newborn diagnosed after delivery of a baby to a mother with low anti-E antibody titres.
    Lee TTM; Clarke P; Prosser-Snelling E
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31501172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal red blood cell alloimmunisation in south western Uganda.
    Natukunda B; Mugyenyi G; Brand A; Schonewille H
    Transfus Med; 2011 Aug; 21(4):262-6. PubMed ID: 21371143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.